Catalio Capital Management, LP Uni Qure N.V. Transaction History
Catalio Capital Management, LP
- $411 Billion
- Q1 2025
A detailed history of Catalio Capital Management, LP transactions in Uni Qure N.V. stock. As of the latest transaction made, Catalio Capital Management, LP holds 830,325 shares of QURE stock, worth $11.6 Million. This represents 2.14% of its overall portfolio holdings.
Number of Shares
830,325
Previous 901,973
7.94%
Holding current value
$11.6 Million
Previous $15.9 Billion
44.75%
% of portfolio
2.14%
Previous 3.48%
Shares
2 transactions
Others Institutions Holding QURE
# of Institutions
175Shares Held
50.8MCall Options Held
2.13MPut Options Held
480K-
Vestal Point Capital, LP New York, NY4.79MShares$67.1 Million3.63% of portfolio
-
Rtw Investments, LP New York, NY4.27MShares$59.7 Million0.74% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.99MShares$55.8 Million3.32% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.76MShares$38.6 Million1.32% of portfolio
-
Abrdn PLC2.75MShares$38.5 Million0.07% of portfolio
About uniQure N.V.
- Ticker QURE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,729,100
- Market Cap $654M
- Description
- uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...